Cargando…
RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes
From its discovery as an adaptive bacterial and archaea immune system, the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system has quickly been developed into a powerful and groundbreaking programmable nuclease technology for the global and precise editing of the genome in...
Autores principales: | Humphrey, Sean E, Kasinski, Andrea L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389696/ https://www.ncbi.nlm.nih.gov/pubmed/25888285 http://dx.doi.org/10.1186/s13045-015-0127-3 |
Ejemplares similares
-
Investigating the Genomic Background of CRISPR-Cas Genomes for
CRISPR-Based Antimicrobials
por: Shim, Hyunjin
Publicado: (2022) -
CRISPR–Cas9-mediated genome editing and guide RNA design
por: Wiles, Michael V., et al.
Publicado: (2015) -
Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease
por: Gratz, Scott J., et al.
Publicado: (2013) -
Targeted genomic rearrangements using CRISPR/Cas technology
por: Choi, Peter S., et al.
Publicado: (2014) -
Exploiting CRISPR–Cas9 technology to investigate individual histone modifications
por: Vasquez, Juan-José, et al.
Publicado: (2018)